Aditxt Inc. - ADTX Company Short-Term Debt

Graphic logo of Aditxt (ADTX)

The asset value of Aditxt (ADTX) reflected in the chart correlates with a strategy to modify immune defense for graft protection without aggressive chemistry. Returns are based on the implementation of AditxtScore diagnostic systems and the creation of tolerance methods. Meanwhile, Aditxt is seeking to expand its reach among laboratories and major clients, as the current metric stands at 0.00, necessitating further scaling of sales.

ADTX (aditxt.com) Company Short-Term Debts history from 07/04/2022 to 07/11/2026

Aditxt Inc. - analytical breakdowns and key metrics (ADTX)

- price and consensus price forecast:
Price Chart Aditxt Corp|ADTX - Fair Value Consensus
- market capitalization data:
Market Value Aditxt, Inc.|ADTX - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Aditxt|ADTX - Book Capitalization|Market Cap to Net Assets Ratio aditxt.com|ADTX - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Aditxt|ADTX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Aditxt Corp|ADTX - Company Total Debt|Debt to Book Capitalization Ratio Aditxt, Inc.|ADTX - Company Long-Term Liabilities|Company Current Liabilities Aditxt
Fundamental company valuation:aditxt.com - ADTX
Product sample of Aditxt Corp

The development of Aditxt (ADTX) therapeutic platforms requires a large-scale expansion of the client base, making the monitoring of the short-term debt portfolio critical for assessing liquidity. The ratio of current liabilities to working capital on this chart determines the balance between financial stability and the speed of expansion: reducing debt minimizes default risk but may limit investments in operating profit growth.

Competitor analysis

Company Short-Term Debt argenx (ARGX)|BNTX: Company Short-Term Loans and Borrowings|ABVX (Abivax) - Company Short-Term Debt|ADMA Corp (ADMA) - Company Current Liabilities|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com (IMVT)|Kiniksa (KNSA) - Company Current Liabilities|Company Short-Term Loans and Borrowings Grifols SA (GRFS)|Company Short-Term Debts ADPT|Celldex Corp - Short-Term Debt Volume|AUPH: Company Short-Term Debt|BCRX: Company Current Liabilities|VERA (Vera Therapeutics) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|PHVS (Pharvaris Corp) - Company Current Liabilities|Company Short-Term Debts ABCL|Company Short-Term Debt Tourmaline Bio, Inc. TRML|Company Short-Term Indebtedness precigen.com (PGEN)|PHAR: Company Short-Term Debts|Short-Term Debt Nektar Therapeutics Inc NKTR|Upstream Bio Corp - Company Short-Term Debts|ZBIO - Company Short-Term Debts|Company Short-Term Debts Immunome, Inc.|gossamerbio.com (GOSS) - Company Short-Term Indebtedness|KALV: Company Short-Term Debts|Short-Term Debt Volume Septerna, Inc. (SEPN)|Company Current Liabilities Pieris Pharmaceuticals Inc|Amount of Current Liabilities Savara Pharma SVRA|RIGL - Company Current Liabilities|ANAB - Company Short-Term Indebtedness|Company Current Liabilities Astria Therapeutics, Inc. ATXS|ENGN - Amount of Current Liabilities|RAPT: Company Short-Term Debts|Aerovate Therapeutics (JBIO) - Company Short-Term Debts|Company Short-Term Debts Aclaris Therapeutics (ACRS)|Company Short-Term Indebtedness kyvernatx.com (KYTX)|Company Current Liabilities Tiziana Life Sciences Ltd|Amount of Current Liabilities Cabaletta Bio Inc. CABA|VTYX - Company Current Liabilities|Theratechnologies, Inc - Company Short-Term Indebtedness|Company Short-Term Debt Avalo Therapeutics, Inc|ELDN - Current Liabilities|Company Short-Term Debts Agenus Inc. AGEN|Climb Bio Inc. (CLYM) - Company Short-Term Loans and Borrowings|ZURA (Zura Bio) - Company Short-Term Debts|Company Short-Term Debts ATYR|Adagene (ADAG) - Company Short-Term Debt|Company Short-Term Loans and Borrowings IMA (ikenaoncology.com)|Shattuck Labs - Company Short-Term Debt|Company Current Liabilities Equillium Inc EQ|Connect Pharma - Company Short-Term Debts|Immunic, Inc. (IMUX) - Company Short-Term Debts|Company Current Liabilities atarabio.com ATRA|InflaRx (IFRX) - Company Short-Term Loans and Borrowings|XFOR: Company Short-Term Debts|Short-Term Debt Volume ACET|Company Short-Term Debt CELU (Celularity Inc.)|Company Current Liabilities INMB (INmune Bio Corporation)|Barinthus Biotherapeutics - Company Short-Term Debt|KZR - Company Current Liabilities|SAB Biotherapeutics, Inc. - Company Current Liabilities|AKTX: Company Short-Term Debts|Company Short-Term Debt enlivex.com|Q32 Bio (QTTB) - Company Short-Term Indebtedness|Company Short-Term Debts GOVX (GeoVax Labs, Inc.)|Short-Term Debt edesabiotech.com|Company Short-Term Debts IBIO|Company Short-Term Debts carismatx.com (CARM)|XTLB - Company Short-Term Debts|Company Short-Term Indebtedness Bolt Biotherapeutics Inc. BOLT|Company Short-Term Debts HCWB (HCW Biologics Inc)|Aptevo Therapeutics (APVO) - Short-Term Debt Volume|AIM - Company Current Liabilities|Amount of Current Liabilities GRI Bio Inc|Company Current Liabilities XORTX (XRTX)|Company Short-Term Indebtedness Vyome Therapeutics (HIND)|Company Current Liabilities Revelation Biosciences|Amount of Current Liabilities indaptusrx.com (INDP)|Company Short-Term Debts SCNI (Scinai Immunotherapeutics Ltd.)|Company Short-Term Debts CalciMedica Inc CALI|Affimed Therapeutics (AFMD) - Company Short-Term Debts|Allakos Inc. (ALLK) - Company Short-Term Indebtedness|HOOK - Company Current Liabilities|Amount of Current Liabilities IGM Biosciences|Company Current Liabilities iTeos Therapeutics, Inc. (ITOS)|Company Short-Term Indebtedness OCEA|TCBP - Company Short-Term Debt|Current Liabilities Third Harmonic Bio Inc (THRD)